Citigroup Maintains Buy on Natera, Raises Price Target to $480

10/6/2026
Impact: 75
Healthcare

Citigroup analyst Albert Hu has maintained a 'Buy' rating on Natera (NASDAQ: NTRA) and increased the price target from $365 to $480. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: